Item 8.01. Other Events.
On January 5, 2021, Cerecor Inc. (the "Company") issued a press release
announcing top line data from its proof-of-concept clinical trial of CERC-002 in
patients with COVID-19 induced Acute Respiratory Distress Syndrome ("ARDS"). On
January 5, 2021, the Company also posted on its website an informational
presentation regarding this top line data. Copies of the press release and
informational presentation are attached hereto as Exhibits 99.1 and 99.2,
respectively, and are incorporated herein in their entirety by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. Description
99.1 Press Release dated January 5, 2021.
99.2 Informational Presentation.
1
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses